We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Beats Stock Market Upswing: What Investors Need to Know
Read MoreHide Full Article
In the latest close session, Medical Properties (MPW - Free Report) was up +1.56% at $5.22. The stock's change was more than the S&P 500's daily gain of 1.07%. Elsewhere, the Dow gained 1.12%, while the tech-heavy Nasdaq added 1.37%.
The health care real estate investment trust's shares have seen an increase of 2.59% over the last month, surpassing the Finance sector's loss of 2.19% and the S&P 500's gain of 1.08%.
Analysts and investors alike will be keeping a close eye on the performance of Medical Properties in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.16, reflecting no change from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $237.84 million, up 5.32% from the prior-year quarter.
MPW's full-year Zacks Consensus Estimates are calling for earnings of $0.63 per share and revenue of $945.01 million. These results would represent year-over-year changes of -21.25% and -5.08%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Medical Properties. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.58% increase. Medical Properties currently has a Zacks Rank of #2 (Buy).
With respect to valuation, Medical Properties is currently being traded at a Forward P/E ratio of 8.19. This signifies a discount in comparison to the average Forward P/E of 11.3 for its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 75, which puts it in the top 31% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Beats Stock Market Upswing: What Investors Need to Know
In the latest close session, Medical Properties (MPW - Free Report) was up +1.56% at $5.22. The stock's change was more than the S&P 500's daily gain of 1.07%. Elsewhere, the Dow gained 1.12%, while the tech-heavy Nasdaq added 1.37%.
The health care real estate investment trust's shares have seen an increase of 2.59% over the last month, surpassing the Finance sector's loss of 2.19% and the S&P 500's gain of 1.08%.
Analysts and investors alike will be keeping a close eye on the performance of Medical Properties in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.16, reflecting no change from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $237.84 million, up 5.32% from the prior-year quarter.
MPW's full-year Zacks Consensus Estimates are calling for earnings of $0.63 per share and revenue of $945.01 million. These results would represent year-over-year changes of -21.25% and -5.08%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Medical Properties. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.58% increase. Medical Properties currently has a Zacks Rank of #2 (Buy).
With respect to valuation, Medical Properties is currently being traded at a Forward P/E ratio of 8.19. This signifies a discount in comparison to the average Forward P/E of 11.3 for its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 75, which puts it in the top 31% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.